Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factorsYafeng Wang(Nanjing Drum Tower Hospital), Jianghuai Liu(Model Animal Research Center)Nature CommunicationsMarch 18, 202210.1038/s41467-022-29120-yCited by 14SaveCiteExport RISWatch citationsRelated PapersConcomitant type I IFN and M-CSF signaling reprograms monocyte differentiation and drives pro-tumoral arginase production|EBioMedicine|2018|24IL-6/ERK signaling pathway participates in type I IFN-programmed, unconventional M2-like macrophage polarization|Scientific Reports|2023|23